1159823-70-7 Usage
Uses
Used in Pharmaceutical Chemistry:
2-Benzyl-2,5-diazaspiro[3.4]octane is utilized as a key component in the development of new drugs and biologically active molecules. Its distinctive architecture allows for the creation of compounds with potential therapeutic applications, making it a promising candidate for further research and development in the pharmaceutical industry.
Used in Organic Synthesis:
In the field of organic synthesis, 2-benzyl-2,5-diazaspiro[3.4]octane serves as a starting material for the synthesis of various heterocyclic compounds. These heterocyclic compounds often exhibit significant biological activities, which can be harnessed for the creation of novel pharmaceutical agents and other bioactive substances.
Used in Medicinal Chemistry Research:
2-benzyl-2,5-diazaspiro[3.4]octane has garnered research interest due to its pharmacological properties and potential therapeutic applications. Scientists are exploring its use in medicinal chemistry to understand its interactions with biological targets and to develop new therapeutic agents based on its structure.
Overall, 2-benzyl-2,5-diazaspiro[3.4]octane holds substantial relevance in both medicinal and organic chemistry, making it a compound of significant interest for further exploration and study.
Check Digit Verification of cas no
The CAS Registry Mumber 1159823-70-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,9,8,2 and 3 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1159823-70:
(9*1)+(8*1)+(7*5)+(6*9)+(5*8)+(4*2)+(3*3)+(2*7)+(1*0)=177
177 % 10 = 7
So 1159823-70-7 is a valid CAS Registry Number.
1159823-70-7Relevant articles and documents
2 - (2, 4, 5 - SUBSTITUTED -ANILINO) PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
-
, (2013/03/26)
The present invention relates to certain 2-(2,4,5-substituted-anilino) pyrimidine compounds and pharmaceutically acceptable salts thereof which may be useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of epidermal growth factor receptor (for example the L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant). Such compounds and salts thereof may be useful in the treatment or prevention of a number of different cancers. The invention also relates to pharmaceutical compositions comprising said compounds and salts thereof, especially useful polymorphic forms of these compounds and salts, intermediates useful in the manufacture of said compounds and to methods of treatment of diseases mediated by various different forms of EGFR using said compounds and salts thereof.
